Related Experiment Videos
[The HLA system and diabetes mellitus]
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|January 15, 1981
Summary
Certain human leukocyte antigen (HLA) types increase the risk of juvenile onset diabetes. Conversely, other HLA antigens appear protective, while maturity onset diabetes is not HLA-associated.
Area of Science:
- Immunogenetics
- Endocrinology
- Human Genetics
Context:
- Diabetes mellitus is a complex endocrine disorder with largely unknown pathogenesis.
- Recent research highlights a significant association between Human Leukocyte Antigen (HLA) system and diabetes.
- Understanding these genetic links is crucial for unraveling disease etiology.
Purpose:
- To investigate the relationship between specific HLA antigens and the risk of developing different types of diabetes mellitus.
- To identify HLA alleles associated with increased susceptibility or protection against diabetes.
- To differentiate the genetic underpinnings of juvenile onset diabetes (JOD) from maturity onset diabetes (MOD).
Summary:
- Specific HLA antigens (e.g., HLA-A1, A2, B8, DRW3, DRW4) are linked to an elevated risk of JOD requiring insulin.
- The risk is additive for individuals with multiple specific HLA-B alleles.
- Conversely, HLA antigens like HLA-B7, DW2, DRW2, and A11 demonstrate a protective effect against JOD.
- Maturity onset diabetes (MOD) and MODY are genetically distinct and not associated with the HLA system, indicating different etiopathogenesis compared to JOD.
Impact:
- Identifies specific genetic markers (HLA antigens) for JOD risk stratification.
- Provides insights into the immunogenetic basis of diabetes, potentially guiding future research.
- Establishes a clear genetic distinction between JOD and MOD, supporting separate diagnostic and therapeutic approaches.
- Highlights the potential for HLA-based protective strategies or risk prediction in susceptible populations.